GSK R&D to Revenue

GSK plc American Depositary Shares (Each representing two Ordinary Shares) · R&D to Revenue

GSK logo

GSK R&D to Revenue

Latest reported22.98%
GSK FY R&D/Revenue (7.91% → 22.98%)
High-resolution chart · PNG

GSK r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
22.9834%
17.5198%
17.2942%
16.4916%
17.76%
13.1353%
12.5763%
11.8685%
12.8039%
12.4816%
14.2959%
14.4962%
12.9636%
13.1928%
13.4553%
15.1557%
14.0052%
14.7216%
14.3335%
14.8848%
14.4783%
14.5302%
13.0171%
13.6715%
12.4715%
13.972%
14.947%
14.5685%
14.386%
13.9192%
14.6806%
0%
15.1697%
14.9899%
14.5264%
13.9829%
13.2117%
12.5681%
11.1705%
8.5583%
7.9076%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.